Feb 11 (Reuters) - Health Canada:
* HEALTH CANADA SUSPENDS LICENCE FOR PERFORMANCE PLUS CAPSULES: PRODUCT MAY POSE SERIOUS HEALTH RISKS
* HEALTH CANADA - SUSPENDED PRODUCT LICENCE FOR PERFORMANCE PLUS CAPSULES AS IT MAY POSE SERIOUS HEALTH RISKS, SUCH AS HEART ATTACK & STROKE
* HEALTH CANADA SAYS LABORATORY TESTING FOUND PERFORMANCE PLUS CAPSULE CONTAINS A PRESCRIPTION DRUG SILDENAFIL THAT IS NOT LISTED ON PRODUCT LABEL